Trial Profile
A Phase I Clinical Trial to Investigate the Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertension; Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 28 Dec 2016 Status changed from not yet recruiting to completed.
- 24 Jun 2014 New trial record